echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Pfizer's tick-borne encephalitis vaccine TICOVAC receives FDA approval

    Pfizer's tick-borne encephalitis vaccine TICOVAC receives FDA approval

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationFan Dongdong

    A few days ago, the U.


    Dr.


    Tick-borne encephalitis is a viral infection, and the virus is transmitted to humans mainly through insect bites


    According to the recommendations of the European Center for Disease Control and Prevention (ECDC), people who live or travel to areas where tick-borne encephalitis is endemic should be vaccinated


    The company said that the vaccine was developed with a virus similar to tick-borne encephalitis virus, which can induce patients to produce neutralizing antibodies against tick-borne encephalitis virus


    In addition, the trial also found that patients vaccinated with TICOVAC vaccine are generally well tolerated and there are no unexpected adverse events (AE) or serious adverse events related to the vaccine


    Not long ago, the FDA also approved the revised emergency use authorization of Pfizer and BioNTech's COVID-19 vaccine, allowing patients with weakened immune functions to receive a third booster injection


    Reference source:

    1.


    2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.